Precision Medicine in Oncology® | Specialty

Dr. Chachoua on Afatinib for Exon 19 Mutation in Lung Cancer

February 11th 2015

Abraham Chachoua, MD, associate director of cancer services at NYU Langone Medical Center, talks about targeted treatment for mutations in non-small cell lung cancer and adenocarcinoma.

President Details $215 Million 'Precision Medicine Initiative'

January 31st 2015

The 'precision medicine initiative' proposed by President Barack Obama will require an initial investment of $215 million and consent from 1 million volunteers, with the goal of discovering potential cures for patients with cancer.

Final Thoughts on Improving Outcomes in CRC

January 30th 2015

Impact of Vitamin D on Colorectal Cancer Outcomes

January 30th 2015

Molecular Profiling in Colorectal Cancer

January 30th 2015

Measuring Therapeutic Response in Colon Cancer

January 30th 2015

Third-Line Regorafenib and TAS-102 in mCRC

January 30th 2015

Second-Line Therapy for Metastatic CRC

January 30th 2015

Postoperative Therapy for Metastatic CRC

January 30th 2015

Treatment Selection in RAS Wild-Type mCRC

January 30th 2015

Communication Strategies for Newly Diagnosed mCRC

January 30th 2015

Expanded RAS Testing Required in CRC

January 30th 2015

Exercise and Lifestyle Factors in Patients with mCRC

January 30th 2015

Adjuvant Therapy in Stage II Colon Cancer

January 30th 2015

Molecular Testing in Colorectal Cancer

January 30th 2015

Colorectal Cancer Screening and Prevention

January 30th 2015

Targeted Therapies and Immunotherapies Are Transforming Outcomes in Advanced NSCLC

January 28th 2015

Ten or 15 years ago, a diagnosis of advanced non– small cell lung cancer (NSCLC) led directly to a discussion of chemotherapy.

Joan Lunden and Dr Patrick Borgen Discuss Imaging and Genetic Testing in Breast Cancer

January 23rd 2015

Joan Lunden talks about imaging technology and genetic testing for the early detection of breast cancer with Roy Firestone and Patrick I. Borgen, MD, in advance of her keynote address at the 32nd Miami Breast Cancer Conference.

Precision Medicine Goes Mainstream

January 22nd 2015

"Precision, personalized, individualized, targeted" - most oncologists are well acquainted with these terms. On Tuesday, President Obama introduced this concept to the nation in his State of the Union Address.

Grant Aims to Deliver First Stem-Cell Immunotherapy in Ovarian Cancer

January 19th 2015

The New York State Stem Cell Science Program recently awarded a 4-year $11.9 million grant to Roswell Park Cancer Institute to fund research and development of a stem-cell based treatment for ovarian cancer.